Knowledge, attitude, and practice of patients with diabetes towards diabetic nephropathy, neuropathy and retinopathy.
Pharm Pract (Granada)
; 20(1): 2608, 2022.
Article
in English
| MEDLINE | ID: covidwho-1798626
ABSTRACT
Background:
Epidemiological and knowledge, attitude and practice (KAP) studies about diabetic microvascular complications are lacking. The goals of this study are determining 1) the prevalence of diabetes mellitus subtypes and microvascular complications, 2) the KAP towards the complications and 3) health-seeking behavior, barriers to follow-up, stigma and sources of information.Methods:
A cross-sectional study was conducted from January to October 2020 enrolling 380 Lebanese patients with diabetes asked about socio-demographic and lifestyle characteristics, medical, therapeutic, supplement, and dietary history, KAP scores, health-seeking behavior, stigma, barriers to compliance, and sources of information.Results:
The prevalence of diabetes type II, type I, gestational, and the microvascular complications was 82.23%, 15.65%, 2.12%, and 33.07% respectively. Factors with significant association were 1) good quality of life (ß=-0.03; p=0.005) and presence of microvascular complications (ß=3.58; p=0.001) with knowledge score, 2) good quality of life (ß=-0.01; p=0.02) and absence of the complications (ß=-0.33; p=0.001) with attitude score, 3) advanced age (ß=0.01; p=0.01), no metformin (ß=-0.39; p=0.005), and low-protein diet (ß=0.6; p=0.02) with practice score. Patients visited community pharmacies (41.84%) and clinics (46.32%). Barriers were costs (33.42%) and time (30.53%). Few talked about the complications to the family (19.74%). Sources of information were healthcare workers.Conclusion:
Awareness campaigns should be tailored accordingly to retard the microvascular complications.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Cohort study
/
Observational study
/
Prognostic study
/
Randomized controlled trials
Language:
English
Journal:
Pharm Pract (Granada)
Year:
2022
Document Type:
Article
Affiliation country:
PharmPract.2022.1.2608
Similar
MEDLINE
...
LILACS
LIS